Werewolf Therapeutics, Inc. · NASDAQ:HOWL
MOLL PETER reported a 5.20% stake in Werewolf Therapeutics, Inc. (Schedule 13G)
Event Sep 18, 2026 · Filed Sep 21, 2026
MOLL PETER reported a 5.20% stake in Werewolf Therapeutics, Inc., 2,537,138 shares, as a passive investor on Sep 18, 2026. Filed Sep 21, 2026 (Schedule 13G).
- Stake
- 5.20%
- Shares
- 2,537,138
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| MOLL PETER | 5.20% | 2,537,138 |
Source
Related
- Werewolf Therapeutics, Inc.
- Moll Peter
- Werewolf Therapeutics, Inc. shareholders
- Form 4 · Luke Evnin · Jul 8, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Jul 2, 2026
- Form 4 · Luke Evnin · Jun 29, 2026
- Schedule 13D/A · Ra Capital Management, L.P. · Jun 26, 2026
- Form 4 · Ra Capital Management, L.P. · Jun 22, 2026